NOD proteins: Regulators of inflammation in health and disease

Nature Reviews Immunology

Volumn 14, Issue 1, 2014, Pages 9-23

  Philpott, Dana J ^a   Sorbara, Matthew T ^a   Robertson, Susan J ^a   Croitoru, Kenneth ^b   Girardin, Stephen E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; LIGAND; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PEPTIDOGLYCAN;

ADAPTIVE IMMUNITY; ASTHMA; ATOPY; AUTOPHAGY; BACTERIAL INFECTION; BLAU SYNDROME; CELLULAR DISTRIBUTION; COLON CANCER; CYTOSKELETON; CYTOSOL; ENTEROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HUMAN; IN VIVO STUDY; INFLAMMATION; INTESTINE; INTRACELLULAR SPACE; MICROFLORA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STOMACH CANCER;

ADAPTIVE IMMUNITY; ANIMALS; AUTOPHAGY; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTESTINES; NEOPLASMS; NOD SIGNALING ADAPTOR PROTEINS; PEPTIDOGLYCAN; SIGNAL TRANSDUCTION;

EID: 84893702846     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3565     Document Type: Review

References (165)

1. Girardin, S. E. et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300, 1584-1587 (2003).
2. Girardin, S. E. et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278, 41702-41708 (2003).
3. Chamaillard, M. et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature Immunol. 4, 702-707 (2003).
4. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
5. Inohara, N. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohns disease. J. Biol. Chem. 278, 5509-5512 (2003).
6. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease. Nature 411, 599-603 (2001).
7. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohns disease. Nature 411, 603-606 (2001).
8. Proell, M., Riedl, S. J., Fritz, J. H., Rojas, A. M. & Schwarzenbacher, R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE 3, e2119 (2008).
9. Girardin, S. E. et al. Identification of the critical residues involved in peptidoglycan detection by Nod1. J. Biol. Chem. 280, 38648-38656 (2005).
10. Tanabe, T. et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23, 1587-1597 (2004).
11. Chin, A. I. et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-194 (2002).
12. Inohara, N. et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-βB. J. Biol. Chem. 274, 14560-14567 (1999).
13. Ogura, Y. et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-βB. J. Biol. Chem. 276, 4812-4818 (2001).
14. Park, J. H. et al. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380-2386 (2007).
15. Sorbara, M. T. et al. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity 39, 858-873 (2013).
16. Barnich, N., Aguirre, J. E., Reinecker, H. C., Xavier, R. & Podolsky, D. K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor- βB activation in muramyl dipeptide recognition. J. Cell Biol. 170, 21-26 (2005).
17. Ogura, Y. et al. Expression of NOD2 in Paneth cells: a possible link to Crohns ileitis. Gut 52, 1591-1597 (2003).
18. Wang, T. T. et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15- defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 285, 2227-2231 (2010).
19. Leung, C. H., Lam, W., Ma, D. L., Gullen, E. A. & Cheng, Y. C. Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan. Eur. J. Immunol. 39, 3529-3537 (2009).
20. Rosenstiel, P. et al. TNFα and IFNγ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001-1009 (2003).
21. Gutierrez, O. et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-βB activation. J. Biol. Chem. 277, 41701-41705 (2002).
22. Kim, Y. G. et al. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9, 496-507 (2011).
23. Takahashi, Y. et al. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J. Vet. Med. Sci. 68, 471-478 (2006).
24. Lee, K. H., Biswas, A., Liu, Y. J. & Kobayashi, K. S. Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J. Biol. Chem. 287, 39800-39811 (2012).
25. Zurek, B. et al. TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS ONE 7, e41255 (2012).
26. Girardin, S. E. et al. CARD4/Nod1 mediates NF-βB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742 (2001).
27. Viala, J. et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immunol. 5, 1166-1174 (2004).
28. Bielig, H. et al. NOD-like receptor activation by outer membrane vesicles from Vibrio cholerae non-O1 non-O139 strains is modulated by the quorum-sensing regulator HapR. Infect. Immun. 79, 1418-1427 (2011).
29. Kaparakis, M. et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 12, 372-385 (2010).
30. Marina-Garcia, N. et al. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. J. Immunol. 182, 4321-4327 (2009).
31. Lee, J. et al. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 284, 23818-23829 (2009).
32. Iyer, J. K. & Coggeshall, K. M. Cutting edge: primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J. Immunol. 186, 3841-3845 (2011).
33. Vavricka, S. R. et al. hPepT1 transports muramyl dipeptide, activating NF-βB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 127, 1401-1409 (2004).
34. Kasper, C. A. et al. Cell-cell propagation of NF-βB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Immunity 33, 804-816 (2010).
35. Fujimoto, Y., Pradipta, A. R., Inohara, N. & Fukase, K. Peptidoglycan as Nod1 ligand; fragment structures in the environment, chemical synthesis, and their innate immunostimulation. Nature Prod. Rep. 29, 568-579 (2012).
36. Hasegawa, M. et al. Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J. Biol. Chem. 281, 29054-29063 (2006).
37. Pradipta, A. R., Fujimoto, Y., Hasegawa, M., Inohara, N. & Fukase, K. Characterization of natural human nucleotide-binding oligomerization domain protein 1 (Nod1) ligands from bacterial culture supernatant for elucidation of immune modulators in the environment. J. Biol. Chem. 285, 23607-23613 (2010).
38. Clarke, T. B. et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Med. 16, 228-231 (2010).
39. Macho Fernandez, E. et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 1050-1059 (2011).
40. Duerr, C. U. et al. Control of intestinal Nod2-mediated peptidoglycan recognition by epithelium-associated lymphocytes. Mucosal Immunol. 4, 325-334 (2011).
41. Philpott, D. J. & Girardin, S. E. Nod-like receptors: sentinels at host membranes. Curr. Opin. Immunol. 22, 428-434 (2010).
42. Travassos, L. H. et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nature Immunol. 11, 55-62 (2010).
43. Lipinski, S. et al. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition. Proc. Natl Acad. Sci. USA 109, 21426-21431 (2012).
44. Kufer, T. A., Kremmer, E., Banks, D. J. & Philpott, D. J. Role for erbin in bacterial activation of Nod2. Infect. Immun. 74, 3115-3124 (2006).
45. McDonald, C. et al. A role for Erbin in the regulation of Nod2-dependent NF-βB signaling. J. Biol. Chem. 280, 40301-40309 (2005).
46. Fukazawa, A. et al. GEF-H1 mediated control of NOD1 dependent NF-βB activation by Shigella effectors. PLoS Pathog. 4, e1000228 (2008).
47. Geddes, K. et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nature Med. 17, 837-844 (2011).
48. Geddes, K. et al. Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect. Immun. 78, 5107-5115 (2010).
49. Le Bourhis, L. et al. Role of Nod1 in mucosal dendritic cells during Salmonella pathogenicity island 1-independent Salmonella enterica serovar Typhimurium infection. Infect. Immun. 77, 4480-4486 (2009).
50. Grimes, C. L., Ariyananda Lde, Z., Melnyk, J. E. & OShea, E. K. The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J. Am. Chem. Soc. 134, 13535-13537 (2012).
51. Mo, J. et al. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J. Biol. Chem. 287, 23057-23067 (2012).
52. Laroui, H. et al. L-Ala-α-D-Glu-meso-diaminopimelic acid (DAP) interacts directly with leucine-rich region domain of nucleotide-binding oligomerization domain 1, increasing phosphorylation activity of receptor-interacting serine/threonine-protein kinase 2 and its interaction with nucleotide-binding oligomerization domain 1. J. Biol. Chem. 286, 31003-31013 (2011).
53. Askari, N., Correa, R. G., Zhai, D. & Reed, J. C. Expression, purification, and characterization of recombinant NOD1 (NLRC1): a NLR family member. J. Biotechnol. 157, 75-81 (2012).
54. Zurek, B., Proell, M., Wagner, R. N., Schwarzenbacher, R. & Kufer, T. A. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation. Innate Immun. 18, 100-111 (2012).
55. van Duist, M. M. et al. A new CARD15 mutation in Blau syndrome. Eur. J. Hum. Genet. 13, 742-747 (2005).
56. Kanazawa, N. et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-βB activation: common genetic etiology with Blau syndrome. Blood 105, 1195-1197 (2005).
57. Magalhaes, J. G. et al. Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur. J. Immunol. 41, 1445-1455 (2011).
58. Yang, Y. et al. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282, 36223-36229 (2007).
59. Yeretssian, G. et al. Non-apoptotic role of BID in inflammation and innate immunity. Nature 474, 96-99 (2011).
60. Warner, N. et al. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κaB signaling pathways. Sci. Signal. 6, rs3 (2013).
61. Nachbur, U., Vince, J. E., OReilly, L. A., Strasser, A. & Silke, J. Is BID required for NOD signalling? Nature 488, E4-E6 (2012).
62. Yeretssian, G et al. Yeretssian et al. reply. Nature 488, E6-E8 (2012).
63. Magalhaes, J. G. et al. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 6, 1201-1207 (2005).
64. Legrand-Poels, S. et al. Modulation of Nod2-dependent NF-βB signaling by the actin cytoskeleton. J. Cell Sci. 120, 1299-1310 (2007).
65. Eitel, J. et al. α-PIX and Rac1 GTPase mediate trafficking and negative regulation of NOD2. J. Immunol. 181, 2664-2671 (2008).
66. Stevens, C. et al. The intermediate filament protein, vimentin, is a regulator of NOD2 activity. Gut 62, 695-707 (2013).
67. Keestra, A. M. et al. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496, 233-237 (2013).
68. Zhao, Y. et al. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm. Bowel Dis. 18, 603-612 (2012).
69. Fritz, J. H. et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35, 2459-2470 (2005).
70. Rubino, S. J., Selvanantham, T., Girardin, S. E. & Philpott, D. J. Nod-like receptors in the control of intestinal inflammation. Curr. Opin. Immunol. 24, 398-404 (2012).
71. Kim, Y. G. et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34, 769-780 (2011).
72. Coulombe, F., Fiola, S., Akira, S., Cormier, Y. & Gosselin, J. Muramyl dipeptide induces NOD2-dependent Ly6Chigh monocyte recruitment to the lungs and protects against influenza virus infection. PLoS ONE 7, e36734 (2012).
73. Bansal, K. & Balaji, K. N. Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. J. Biol. Chem. 286, 5823-5835 (2011).
74. Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 17537-17542 (2012).
75. Watanabe, T. et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645-1662 (2010).
76. Magalhaes, J. G. et al. Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. Proc. Natl Acad. Sci. USA 108, 14896-14901 (2011).
77. Magalhaes, J. G. et al. Nod2-dependent TH2 polarization of antigen-specific immunity. J. Immunol. 181, 7925-7935 (2008).
78. Fritz, J. H. et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26, 445-459 (2007).
79. Geddes, K., Magalhaes, J. G. & Girardin, S. E. Unleashing the therapeutic potential of NOD-like receptors. Nature Rev. Drug Discov. 8, 465-479 (2009).
80. Hancock, R. E., Nijnik, A. & Philpott, D. J. Modulating immunity as a therapy for bacterial infections. Nature Rev. Microbiol. 10, 243-254 (2012).
81. Sorbara, M. T. & Philpott, D. J. Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis. Immunol. Rev. 243, 40-60 (2011).
82. Chassaing, B. et al. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyers patches via long polar fimbriae. J. Clin. Invest. 121, 966-975 (2011).
83. Hruz, P. et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation. Proc. Natl Acad. Sci. USA 106, 12873-12878 (2009).
84. Frutuoso, M. S. et al. The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect. 12, 819-827 (2010).
85. Kim, Y. G. et al. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28, 246-257 (2008).
86. Meinzer, U. et al. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 11, 337-351 (2012).
87. Boneca, I. G. et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl Acad. Sci. USA 104, 997-1002 (2007).
88. Sycuro, L. K. et al. Multiple peptidoglycan modification networks modulate Helicobacter pyloris cell shape, motility, and colonization potential. PLoS Pathog. 8, e1002603 (2012).
89. Frirdich, E. et al. Correction: Peptidoglycan-modifying enzyme Pgp1 is required for helical cell shape and pathogenicity traits in. PLoS Pathog. 8, e1002602 (2012).
90. Liu, M. et al. The Legionella pneumophila EnhC protein interferes with immunostimulatory muramyl peptide production to evade innate immunity. Cell Host Microbe 12, 166-176 (2012).
91. Birmingham, C. L. et al. Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy 3, 442-451 (2007).
92. Birmingham, C. L., Smith, A. C., Bakowski, M. A., Yoshimori, T. & Brumell, J. H. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281, 11374-11383 (2006).
93. Ogawa, M. et al. Escape of intracellular Shigella from autophagy. Science 307, 727-731 (2005).
94. Fujita, N. et al. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 19, 2092-2100 (2008).
95. Homer, C. R., Richmond, A. L., Rebert, N. A., Achkar, J. P. & McDonald, C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohns disease pathogenesis. Gastroenterology 139, 1630-1641, 1641.e1-1641. e2 (2010).]
96. Cooney, R. et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nature Med. 16, 90-97 (2010).
97. Lupfer, C. et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nature Immunol. 14, 480-488 (2013).
98. Homer, C. R. et al. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J. Biol. Chem. 287, 25565-25576 (2012).
99. Anand, P. K. et al. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via ERK activation. J. Biol. Chem. (2011).
100. Marchiando, A. M. et al. A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host Microbe 14, 216-224 (2013).
101. Wang, C. et al. Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc. Natl Acad. Sci. USA 109, 11008-11013 (2012).
102. Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005).
103. Wehkamp, J. et al. NOD2 (CARD15) mutations in Crohns disease are associated with diminished mucosal α-defensin expression. Gut 53, 1658-1664 (2004).
104. Simms, L. A. et al. Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohns disease. Gut 57, 903-910 (2008).
105. Biswas, A. et al. Induction and rescue of Nod2-dependent TH1-driven granulomatous inflammation of the ileum. Proc. Natl Acad. Sci. USA 107, 14739-14744 (2010).
106. Robertson, S. J. et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4, 222-231 (2013).
107. Shanahan, M. T. et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut http://dx.doi. org/10.1136/gutjnl-2012-304190 (2013).
108. Van Limbergen, S. et al. CD24-based assessment of NOD2 influence on Paneth cell numbers using intestinal stem cell cultures and genetic association analysis of CD24 in IBD. Gut http://dx.doi. org/10.1136/gutjnl-2013-305077 (2013).
109. Cadwell, K. et al. Virus-plus-susceptibility gene interaction determines Crohns disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145 (2010).
110. Shaw, M. H. et al. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nature Immunol. 10, 1267-1274 (2009).
111. Caetano, B. C. et al. Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur. J. Immunol. 41, 3627-3631 (2011).
112. Zanello, G. et al. Nod2 activates NF-kB in CD4+ T cells but its expression is dispensable for T cell-induced colitis. PLoS ONE (in the press).
113. Jiang, W. et al. Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes. J. Exp. Med. 210, 2465-2476 (2013).
114. van Beelen, A. J. et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669 (2007).
115. Brain, O. et al. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity 39, 521-536 (2013).
116. Zigmond, E. et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090 (2012).
117. Jamontt, J., Petit, S., Clark, N., Parkinson, S. J. & Smith, P. Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice. J. Immunol. 190, 2948-2958 (2013).
118. Noguchi, E., Homma, Y., Kang, X., Netea, M. G. & Ma, X. A. Crohns disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nature Immunol. 10, 471-479 (2009).
119. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
120. Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nature Rev. Gastroenterol. Hepatol. 9, 599-608 (2012).
121. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700-711 (2013).
122. Natividad, J. M. et al. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflamm. Bowel Dis. 18, 1434-1446 (2012).
123. Ubeda, C. et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456 (2012).
124. Hysi, P. et al. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14, 935-941 (2005).
125. Weidinger, S. et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J. Allergy Clin. Immunol. 116, 177-184 (2005).
126. Miceli-Richard, C. et al. CARD15 mutations in Blau syndrome. Nature Genet. 29, 19-20 (2001).
127. Holler, E. et al. Both donor and recipient NOD2/ CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104, 889-894 (2004).
128. Sfriso, P. et al. Blau syndrome, clinical and genetic aspects. Autoimmun. Rev. 12, 44-51 (2012).
129. Albrecht, M., Lengauer, T. & Schreiber, S. Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence. Bioinformatics 19, 2171-2175 (2003).
130. Holler, E., Landfried, K., Meier, J., Hausmann, M. & Rogler, G. The role of bacteria and pattern recognition receptors in GVHD. Int. J. Inflamm. 2010, 814326 (2010).
131. Landfried, K. et al. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin. Exp. Immunol. 159, 87-92 (2010).
132. Penack, O. et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206, 2101-2110 (2009).
133. Companioni, O. et al. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European prospective investigation into cancer-eurgast cohort. Int. J. Cancer 134, 92-101 (2013).
134. Rosenstiel, P. et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell. Microbiol. 8, 1188-1198 (2006).
135. Raju, D. et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142, 1160-1171 (2012).
136. van Heel, D. A. et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohns disease. Lancet 365, 1794-1796 (2005).
137. Netea, M. G. et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174, 6518-6523 (2005).
138. Chamaillard, M. et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl Acad. Sci. USA 100, 3455-3460 (2003).
139. Gardet, A. & Xavier, R. J. Common alleles that influence autophagy and the risk for inflammatory bowel disease. Curr. Opin. Immunol. 24, 522-529 (2012).
140. Inohara, N. et al. An induced proximity model for NF-βB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27823-27831 (2000).
141. Hasegawa, M. et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-βB activation. EMBO J. 27, 373-383 (2008).
142. Krieg, A. et al. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl Acad. Sci. USA 106, 14524-14529 (2009).
143. Bertrand, M. J. et al. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789-801 (2009).
144. Damgaard, R. B. et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46, 746-758 (2012).
145. Ver Heul, A. M., Fowler, C. A., Ramaswamy, S. & Piper, R. C. Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2. J. Biol. Chem. 288, 6890-6902 (2013).
146. Tigno-Aranjuez, J. T., Asara, J. M. & Abbott, D. W. Inhibition of RIP2s tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev. 24, 2666-2677 (2010).
147. Tao, M. et al. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr. Biol. 19, 1255-1263 (2009).
148. Hitotsumatsu, O. et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28, 381-390 (2008).
149. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008).
150. Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl Acad. Sci. USA 106, 15813-15818 (2009).
151. Rehman, A. et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 60, 1354-1362 (2011).
152. Mondot, S. et al. Altered gut microbiota composition in immune-impaired Nod2-/- mice. Gut 61, 634-635 (2012).
153. Chen, G. Y., Shaw, M. H., Redondo, G. & Nunez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060-10067 (2008).
154. Mockelmann, N. et al. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol. 9, 79 (2009).
155. Yao, Q. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases. Semin. Arthritis Rheum. 43, 125-130 (2013).
156. Duan, W. et al. Innate signals from Nod2 block respiratory tolerance and program TH2-driven allergic inflammation. J. Allergy Clin. Immunol. 126, 1284-1293.e10 (2010).
157. Vieira, S. M. et al. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis. J. Immunol. 188, 5116-5122 (2012).
158. Saha, S. et al. PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation. Cell Host Microbe 5, 137-150 (2009).
159. Rosenzweig, H. L. et al. Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan. Arthritis Rheum. 62, 1051-1059 (2010).
160. Joosten, L. A. et al. Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis. Proc. Natl Acad. Sci. USA 105, 9017-9022 (2008).
161. Tsuji, Y. et al. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity 37, 326-338 (2012).
162. Schertzer, J. D. et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 60, 2206-2215 (2011).
163. Amar, J. et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3, 559-572 (2011).
164. Shaw, P. J. et al. Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 34, 75-84 (2011).
165. Tourneur, E. et al. Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients. PLoS Pathog. 9, e1003152 (2013).